-
Mashup Score: 7
Neoadjuvant treatment with gemcitabine, cisplatin, and nab-paclitaxel is feasible and safe prior to resection of intrahepatic cholangiocarcinoma and does not adversely impact perioperative outcomes.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Neoadjuvant treatment with gemcitabine, cisplatin, and nab-paclitaxel is feasible and safe prior to resection of intrahepatic cholangiocarcinoma and does not adversely impact perioperative outcomes.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Neoadjuvant treatment with gemcitabine, cisplatin, and nab-paclitaxel is feasible and safe prior to resection of intrahepatic cholangiocarcinoma and does not adversely impact perioperative outcomes.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Annals of Surgical Oncology – Heterogenous nomenclature describing appendiceal neoplasms has added to uncertainty around their appropriate treatment. Although a recent consensus has established the…
Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 31Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
RT @timnewhook19: #ECGPulseCheck πππ Check out this paper! ππ https://t.co/mvS7FG2UUF https://t.co/yml3Yx0qLM